MPA Revisited: A Phase II Study of Anti-Metastatic Anti-Angiogenic Therapy in Postmenopausal Patients with Hormone Receptor Negative Breast Cancer
Study on Investigational Treatment for Condition X
Not Recruiting
55 years - 100 years
Female
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Breast Cancer
Age:
55 years - 100 years
Gender: Female
Who can participate: Adults aged 18-65 with a diagnosis of Condition X, who are otherwise healthy, may be eligible to participate.
Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The placebo is an inactive substance designed to resemble the investigational treatment.
Updated on
19 Feb 2024.
Study ID: 1011004167 (0607-18)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
